Ara
Toplam kayıt 2, listelenen: 1-2
Paklitaksel/Usnik Asit Kombinasyonunun Meme Kanseri Hücre Hatları Üzerine Etkisi
(Sağlık Bilimleri Enstitüsü, 2017)
Breast Cancer was the second common cancer worldwide in 2012. Using combination of multiple drugs for treatment has been proven to be more affective by research. Paclitaxel is a chemotherapy medication used to treat a ...
Stattic ve/veya Paclitaxel’in Üçlü Negatif Meme Kanseri Üzerine Etkileri
(Sağlık Bilimleri Enstitüsü, 2023-08)
Triple negative breast cancer (TNBC) is an invasive and metastatic cancer with aggressive progress. We aimed to investigate the in vitro and in vivo antiproliferative and in vivo antimetastatic effects of Paclitaxel, used ...